QUAN

COM:QUANTATX

Quanta Therapeutics Inc.

  • Privately Held

Quanta Therapeutics Inc. develops allosteric inhibitors for RAS-driven cancers. The company focuses on creating therapies targeting KRAS mutations.

investor of